You are here
Investing in Health
cluding some 8,500 here in Michigan, making the state home to more Pfizer colleagues than anywhere else in the U.S. or the world.
As has been mentioned, we invest almost $8 billion a year in biomedical research and development. Much of our R&D focus in recent years here in Ann Arbor has been on Lyrica, our breakthrough treatment for nerve-based pain and epilepsy. In fact, hundreds of our colleagues invested 15 years of their careers to develop Lyrica. And that's a good reflection of what we do every day.